Current status and perspectives of nuclear cardiology

被引：0
作者：
Nagara Tamaki
Osamu Manabe
机构：
[1] Kyoto College of Medical Science,Department of Radiology
[2] Kyoto Prefectural University of Medicine,Department of Radiology
[3] Jichi Medical University Saitama Medical Center,undefined
来源：
Annals of Nuclear Medicine | 2024年 / 38卷
关键词：
Coronary artery disease; Cardiovascular disease; PET; SPECT; Radionuclide imaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nuclear cardiology has long been used to identify myocardial ischemia for appropriate treatment strategies for stable coronary artery disease (CAD). After the Ischemia Trial, it is time to reevaluate the significance of ischemia assessment. Functional imaging continues to play pivotal role in detecting microcirculatory disturbances. PET provides a clear image of blood flow distribution and is useful for the quantitative evaluation of myocardial flow reserve (MFR), which plays an important role in predicting treatment strategies and improving prognosis in CAD. Heart failure has become a major area of focus in cardiovascular medicine. Radionuclide imaging has been widely applied in this field. FDG PET is useful in identifying cardiac sarcoidosis and active inflammation. Clinical values of I-123 MIBG and BMIPP SPECT have been reported worldwide from Japan. Additionally, clinical experiences of Tc-99m pyrophosphate imaging have recently gained attention for assessing cardiac amyloidosis. Cardiac PET/CT and PET/MR imaging permit combined assessment of metabolic/functional/structural analyses of various cardiac diseases. While other non-invasive imaging modalities have rapidly been developed, the roles of radionuclide imaging remain to be valuable for early and accurate diagnosis and patient management in most cases of chronic CAD and various cardiovascular diseases.
引用
收藏
页码：20 / 30
页数：10
相关论文
共 905 条
[1]  
Yoshinaga K(2015)Current status of nuclear cardiology in Japan: ongoing efforts to improve clinical standards and to establish evidence J Nucl Cardiol 22 690-699
[2]  
Tamaki N(2004)British Cardiac Society. Myocardial perfusion scintigraphy: the evidence. A consensus conference organised by the British Cardiac Society, the British Nuclear Cardiology Society and the British Nuclear Medicine Society, endorsed by the Royal College of Physicians of London and the Royal College of Radiologists Eur J Nucl Med Mol Imaging 31 261-291
[3]  
Underwood SR(2009)Hybrid SPECT/CT and PET/CT imaging: the next step in noninvasive cardiac imaging Semin Nucl Med 39 341-347
[4]  
Anagnostopoulos C(2007)A randomized trial of exercise treadmill ECG versus stress SPECT myocardial perfusion imaging as an initial diagnostic strategy in stable patients with chest pain and suspected CAD: cost analysis J Nucl Cardiol 14 174-186
[5]  
Cerqueira M(1998)Exercise echocardiography or exercise SPECT imaging? A metaanalysis of diagnostic test performance JAMA 280 913-920
[6]  
Ell PJ(2002)American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines) Circulation 106 1883-1892
[7]  
Flint EJ(2008)Incremental prognostic value of cardiac function assessed by ECG-gated myocardial perfusion SPECT for the prediction of future acute coronary syndrome Circ J 72 2035-2039
[8]  
Harbinson M(2007)Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease J Nucl Cardiol 14 521-528
[9]  
Kaufmann PA(2007)The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis J Am Coll Cardiol 49 227-237
[10]  
Di Carli MF(2008)Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study Eur J Nucl Med Mol Imaging 35 319-328
12345678910